In a nutshell This study compared the risk of severe hypoglycemia (dangerously low blood glucose levels) with insulin glargine-100 (Lantus) and insulin glargine-300 (Toujeo) for patients with type 1 diabetes (T1D). It found that both medications improved glucose control, and insulin glargine-300 had a lower risk of hypoglycemia. Some background T1D is...
Read MoreIn a nutshell The aim of this study was to investigate blood glucose control and rates of hypoglycemia (dangerously low blood glucose levels) when diabetic patients were switched from their basal insulin to insulin degludec (Tresiba). The main finding of this study was that patients who were switched to insulin degludec had improved blood glucose control...
Read MoreIn a nutshell This study is examining the safety and effectiveness of a new insulin plan for people with type 2 diabetes (T2D) that are already being treated with basal insulin. The new insulin being evaluated is a once-a-week administration of insulin instead of daily injections of basal insulin, which should be substantially more convenient for...
Read More
In a nutshell This study examined the safety of insulin degludec in patients with type 1 diabetes. Some background Patients with type1 diabetes (T1D) inject both...
Read MoreIn a nutshell This study aimed to examine the impact of dietary changes on body weight in patients taking insulin detemir (Levemir). Some background Type 2 diabetes is a long-term, progressive disease caused due to resistance to insulin. A widely used treatment option is the administration of insulin. Insulin detemir is a...
Read More
